Accelerating reliable multiscale quantum refinement of protein–drug systems enabled by machine learning
0301 basic medicine
SARS-CoV-2
Science
Q
Molecular Dynamics Simulation
Antiviral Agents
Article
COVID-19 Drug Treatment
Machine Learning
03 medical and health sciences
Quantum Theory
Humans
Coronavirus 3C Proteases
DOI:
10.1038/s41467-024-48453-4
Publication Date:
2024-05-16T19:01:53Z
AUTHORS (4)
ABSTRACT
Biomacromolecule structures are essential for drug development and biocatalysis. Quantum refinement (QR) methods, which employ reliable quantum mechanics (QM) methods in crystallographic refinement, showed promise improving the structural quality or even correcting structure of biomacromolecules. However, vast computational costs complex mechanics/molecular (QM/MM) setups limit QR applications. Here we incorporate robust machine learning potentials (MLPs) multiscale ONIOM(QM:MM) schemes to describe core parts (e.g., drugs/inhibitors), replacing expensive QM method. Additionally, two levels MLPs combined first time overcome MLP limitations. Our unique MLPs+ONIOM-based achieve QM-level accuracy with significantly higher efficiency. Furthermore, our refinements provide evidence existence bonded nonbonded forms Food Drug Administration (FDA)-approved nirmatrelvir one SARS-CoV-2 main protease structure. This study highlights that powerful accelerate QRs protein-drug complexes, promote broader applications more atomistic insights into development.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (78)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....